Merdad Parsey is Chief Medical Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 100,189 shares of GILD, which is worth approximately $9 Million. The most recent transaction as insider was on Oct 01, 2024, when has been sold 2,000 shares (Common Stock) at a price of $83.83 per share, resulting in proceeds of $167,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
3.95% 3M change
42.86% 12M change
Total Value Held $9 Million

Merdad Parsey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
SELL
Open market or private sale
$167,660 $83.83 p/Share
2,000 Reduced 1.96%
100,189 Common Stock
Sep 12 2024
SELL
Open market or private sale
$1,795,287 $84.5 p/Share
21,246 Reduced 17.21%
102,189 Common Stock
Sep 12 2024
BUY
Exercise of conversion of derivative security
$1,448,000 $57.92 p/Share
25,000 Added 16.84%
123,435 Common Stock
Sep 10 2024
SELL
Payment of exercise price or tax liability
$143,823 $81.44 p/Share
1,766 Reduced 1.76%
98,435 Common Stock
Sep 10 2024
BUY
Exercise of conversion of derivative security
-
3,821 Added 3.67%
100,201 Common Stock
Jul 01 2024
SELL
Open market or private sale
$137,260 $68.63 p/Share
2,000 Reduced 2.03%
96,380 Common Stock
Jun 10 2024
SELL
Payment of exercise price or tax liability
$113,796 $65.25 p/Share
1,744 Reduced 1.74%
98,380 Common Stock
Jun 10 2024
BUY
Exercise of conversion of derivative security
-
3,820 Added 3.68%
100,124 Common Stock
Apr 01 2024
SELL
Open market or private sale
$145,920 $72.96 p/Share
2,000 Reduced 2.03%
96,304 Common Stock
Mar 10 2024
SELL
Payment of exercise price or tax liability
$360,801 $75.12 p/Share
4,803 Reduced 4.66%
98,304 Common Stock
Mar 10 2024
BUY
Exercise of conversion of derivative security
-
10,401 Added 9.16%
103,107 Common Stock
Feb 29 2024
SELL
Open market or private sale
$598,650 $72.74 p/Share
8,230 Reduced 8.15%
92,706 Common Stock
Feb 28 2024
SELL
Open market or private sale
$146,360 $73.18 p/Share
2,000 Reduced 1.94%
100,936 Common Stock
Jan 31 2024
SELL
Payment of exercise price or tax liability
$1,855,466 $78.26 p/Share
23,709 Reduced 18.77%
102,616 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
76,853 Added 37.83%
126,325 Common Stock
Dec 10 2023
SELL
Payment of exercise price or tax liability
$100,276 $79.02 p/Share
1,269 Reduced 1.74%
71,640 Common Stock
Dec 10 2023
BUY
Exercise of conversion of derivative security
-
2,779 Added 3.67%
72,909 Common Stock
Sep 12 2023
SELL
Open market or private sale
$115,561 $76.99 p/Share
1,501 Reduced 2.1%
70,130 Common Stock
Sep 10 2023
SELL
Payment of exercise price or tax liability
$97,128 $76.0 p/Share
1,278 Reduced 1.75%
71,631 Common Stock
Sep 10 2023
BUY
Exercise of conversion of derivative security
-
2,779 Added 3.67%
72,909 Common Stock
Jun 13 2023
SELL
Open market or private sale
$114,196 $76.9 p/Share
1,485 Reduced 4.81%
29,402 Common Stock
Jun 10 2023
SELL
Payment of exercise price or tax liability
$101,087 $78.12 p/Share
1,294 Reduced 4.02%
30,887 Common Stock
Jun 10 2023
BUY
Exercise of conversion of derivative security
-
2,779 Added 7.95%
32,181 Common Stock
Mar 13 2023
SELL
Open market or private sale
$483,892 $78.99 p/Share
6,126 Reduced 8.03%
70,130 Common Stock
Mar 10 2023
SELL
Payment of exercise price or tax liability
$423,576 $79.5 p/Share
5,328 Reduced 6.53%
76,256 Common Stock

Also insider at

SGMT
Sagimet Biosciences Inc.
MP

Merdad Parsey

Chief Medical Officer
Foster City, CA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD